Uncategorized

Integral Diagnostics And 2 Other ASX Stocks That May Be Trading Below Estimated Value

As the Australian market navigates a period of fluctuating performance, with recent gains tempered by external pressures such as rising oil prices and missed opportunities in the AI sector, investors are on the lookout for stocks that may be trading below their estimated value. In this environment, identifying undervalued stocks requires careful analysis of fundamentals and market conditions, making Integral Diagnostics and two other ASX-listed companies worthy of consideration for those seeking potential value investments.

Top 10 Undervalued Stocks Based On Cash Flows In Australia

Name

Current Price

Fair Value (Est)

Discount (Est)

Wrkr (ASX:WRK)

A$0.11

A$0.21

46.7%

Web Travel Group (ASX:WEB)

A$2.44

A$4.77

48.8%

Symal Group (ASX:SYL)

A$2.58

A$4.79

46.1%

ReadyTech Holdings (ASX:RDY)

A$1.35

A$2.48

45.5%

Nuix (ASX:NXL)

A$1.43

A$2.56

44.2%

Lovisa Holdings (ASX:LOV)

A$22.21

A$41.97

47.1%

Judo Capital Holdings (ASX:JDO)

A$1.395

A$2.51

44.4%

Integral Diagnostics (ASX:IDX)

A$2.11

A$3.97

46.8%

Capricorn Metals (ASX:CMM)

A$13.56

A$26.17

48.2%

Boss Energy (ASX:BOE)

A$1.32

A$2.63

49.8%

Click here to see the full list of 39 stocks from our Undervalued ASX Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Overview: Integral Diagnostics Limited is a healthcare services company that offers diagnostic imaging services to medical professionals and their patients in Australia and New Zealand, with a market cap of A$785.95 million.

Operations: The company’s revenue is primarily derived from the operation of diagnostic imaging facilities, amounting to A$767.82 million.

Estimated Discount To Fair Value: 46.8%

Integral Diagnostics is trading at A$2.11, significantly below its estimated future cash flow value of A$3.97, indicating potential undervaluation based on discounted cash flows. Despite a dividend yield of 3.46% not being well covered by earnings or free cash flows, the company has shown strong earnings growth of 147.8% over the past year and forecasts suggest continued robust profit growth at 32.76% annually. However, interest payments are not well covered by earnings, which could pose financial challenges ahead amidst ongoing strategic expansion efforts including new site openings and M&A opportunities.

ASX:IDX Discounted Cash Flow as at May 2026

Overview: Nuix Limited offers investigative analytics and intelligence software solutions across various regions including Asia Pacific, the Americas, Europe, the Middle East, and Africa, with a market cap of A$484.42 million.

Source link

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *